Neumeier Poma Investment Counsel LLC Pacira Bio Sciences, Inc. Transaction History

Neumeier Poma Investment Counsel LLC

$1.06 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$27.7 - $35.48 $425,472 - $544,972	-15,360 Reduced 9.19%	151,810 $4.44 Million
Q4 2023 Feb 13, 2024	SELL	$26.32 - $34.31 $2.59 Million - $3.38 Million	-98,450 Reduced 37.06%	167,170 $5.64 Million
Q3 2023 Nov 09, 2023	BUY	$30.68 - $40.09 $481,676 - $629,413	15,700 Added 6.28%	265,620 $8.15 Million
Q2 2023 Aug 10, 2023	SELL	$36.12 - $47.5 $274,512 - $361,000	-7,600 Reduced 2.95%	249,920 $10 Million
Q1 2023 May 10, 2023	SELL	$35.53 - $43.38 $677,557 - $827,256	-19,070 Reduced 6.89%	257,520 $10.5 Million
Q4 2022 Feb 10, 2023	BUY	$38.19 - $57.45 $468,782 - $705,198	12,275 Added 4.64%	276,590 $10.7 Million
Q3 2022 Nov 09, 2022	SELL	$51.24 - $58.89 $4.38 Million - $5.03 Million	-85,385 Reduced 24.42%	264,315 $14.1 Million
Q2 2022 Aug 10, 2022	BUY	$51.49 - $81.64 $1.66 Million - $2.63 Million	32,275 Added 10.17%	349,700 $20.4 Million
Q1 2022 May 11, 2022	SELL	$60.03 - $76.49 $625,812 - $797,408	-10,425 Reduced 3.18%	317,425 $24.2 Million
Q4 2021 Feb 11, 2022	SELL	$47.97 - $62.21 $14.1 Million - $18.3 Million	-294,250 Reduced 47.3%	327,850 $19.7 Million
Q3 2021 Nov 10, 2021	SELL	$54.64 - $61.3 $1.33 Million - $1.5 Million	-24,430 Reduced 3.78%	622,100 $34.8 Million
Q2 2021 Aug 12, 2021	BUY	$59.18 - $69.99 $2.58 Million - $3.06 Million	43,670 Added 7.24%	646,530 $39.2 Million
Q1 2021 May 12, 2021	BUY	$59.31 - $78.82 $338,956 - $450,456	5,715 Added 0.96%	602,860 $42.3 Million
Q4 2020 Feb 10, 2021	BUY	$50.47 - $66.26 $8.35 Million - $11 Million	165,445 Added 38.32%	597,145 $35.7 Million
Q3 2020 Nov 10, 2020	BUY	$51.97 - $63.0 $22.4 Million - $27.2 Million	431,700 New	431,700 $26 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$156 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$103 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$96.6 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$39.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$38.5 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neumeier Poma Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neumeier Poma Investment Counsel LLC with notifications on news.

Account